NME2P1: A Potential Drug Target Or Biomarker (G283458)

NME2P1: A Potential Drug Target Or Biomarker

NME2P1, also known as NME2 pseudogene 1, is a gene that has been identified in the human body as a potential drug target or biomarker. NME2P1 is a non-coding RNA molecule that has been shown to play a role in the regulation of cellular processes that are important for a variety of biological processes, including cell growth, differentiation, and survival.

One of the key features of NME2P1 is its ability to interact with and modulate the activity of the protein NME2, which is a known regulator of many cellular processes. NME2P1 has been shown to play a role in the regulation of NME2 activity, which could potentially make it a useful drug target or biomarker.

In addition to its role in regulating NME2 activity, NME2P1 has also been shown to be involved in the regulation of many other cellular processes. For example, NME2P1 has been shown to play a role in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. NME2P1 has also been shown to be involved in the regulation of cell signaling pathways, which are important for the regulation of a wide range of cellular processes.

The potential utility of NME2P1 as a drug target or biomarker is based on its ability to interact with and modulate the activity of NME2, as well as its involvement in a wide range of cellular processes. This suggests that NME2P1 may be a useful target for the development of new pharmaceuticals for a variety of diseases, including those that are characterized by the over-expression or deregulation of NME2.

In addition to its potential as a drug target or biomarker, NME2P1 is also of interest as a potential therapeutic agent for a variety of diseases. For example, NME2P1 has been shown to play a role in the regulation of cell signaling pathways, which could potentially make it a useful target for the treatment of diseases that are characterized by the disruption of these pathways.

Overall, the potential utility of NME2P1 as a drug target or biomarker is based on its ability to interact with and modulate the activity of NME2, as well as its involvement in a wide range of cellular processes. Further research is needed to fully understand the potential utility of NME2P1 as a therapeutic agent for a variety of diseases.

Protein Name: NME2 Pseudogene 1

Functions: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (By similarity)

The "NME2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NME2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6 | NOL7 | NOL8 | NOL9 | NOLC1 | NOM1 | NOMO1 | NOMO2 | NOMO3 | Non-protein coding RNA 185 | NONO | NOP10 | NOP14 | NOP14-AS1 | NOP16 | NOP2 | NOP53 | NOP56 | Nop56p-associated pre-rRNA complex | NOP58 | NOP9 | NOPCHAP1 | NORAD | NOS1 | NOS1AP | NOS2 | NOS2P1 | NOS2P2 | NOS2P3 | NOS3 | NOSIP | NOSTRIN | Notch ligands | Notch receptor | Notch Transcriptional Activation Complex | NOTCH1 | NOTCH2 | NOTCH2NLA | NOTCH2NLC | NOTCH3 | NOTCH4 | NOTO | NOTUM | NOVA1 | NOVA1-DT | NOVA2 | NOX1 | NOX3 | NOX4 | NOX5 | NOXA1 | NOXO1 | NOXRED1